Definium Therapeutics, Inc. (DFTX) vs LifeStance Health Group, Inc. (LFST)

A side-by-side comparison of Definium Therapeutics, Inc. and LifeStance Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DFTX vs LFST

growth of $100 · dividends reinvested · last 5y
DFTX -34.9% (-8.2%/yr)LFST -44.2% (-11.0%/yr)DFTX compounded faster over this window
050100Start $10020222023202420252026$65$56
DFTX LFST

DFTX vs LFST: by the numbers

  • •DFTX is the larger company ($4.64B vs $4.64B market cap).
  • •LFST is profitable (3.19% net margin) while DFTX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricDFTXLFST
P/E ratioN/A92.24
Forward P/EN/A74.53
P/S ratioN/A2.93
P/B ratio5.053.14
EV / EBITDAN/A34.70
FCF yieldN/A3.75%

Profitability

MetricDFTXLFST
Gross margin0.00%33.56%
Operating margin0.00%4.95%
Net margin0.00%3.19%
ROE-38.51%3.43%
ROIC-23.81%3.03%

Growth (annualized)

MetricDFTXLFST
Revenue CAGR (5Y)N/A24.79%
Total return CAGR (5Y)1.43%-1.46%

Frequently asked

Is DFTX or LFST more profitable?
LFST runs the higher net margin — DFTX at 0.00% versus LFST at 3.19%.
How have DFTX and LFST total returns compared?
Over the past 5 years, DFTX delivered 1.43% and LFST delivered -1.46% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.